François B, Garcia Sanchez M, Eggimann P, et al. Suvratoxumab reduces staphylococcus aureus pneumonia in high-risk icu patients: results of the SAATELLITE Study. Am J Resp Crit Care Med. 2019;199:A7358.
Weinig risico op CTEPH na COVID-19-opname
jan 2025 | Pulmonale hypertensie, Virale infecties